Cell-cycle checkpoints and cancer

Kastan, Michael B., Bartek, Jiri·2004·Nature
DOI 10.1038/nature03097

Cited by (1,008)

Items 1,001–1,008 of 1,008

  1. Combined CDKN1A/TP53 mutation in bladder cancer is a therapeutic target
    Liu, Yang, Kwiatkowski, David J. · 2015 · Molecular Cancer Therapeutics
  2. Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response
    Jullien, Laurent, Mestre, Marie, Roux, Pierre, Gire, Véronique · 2013 · Nucleic Acids Research
  3. DNA damage response in proliferating Müller glia in the mammalian retina
    Nomura-Komoike, Kaori, Saitoh, Fuminori, Komoike, Yuta, Fujieda, Hiroki · 2016 · Investigative Opthalmology & Visual Science
  4. Tenacissoside G synergistically potentiates inhibitory effects of 5-fluorouracil to human colorectal cancer
    Wang, Kaichun, Liu, Wei, Xu, Qinfen, Gu, Chao, Hu, Daode · 2021 · Phytomedicine
  5. CDK2 and PKA mediated-sequential phosphorylation is critical for p19INK4d function in the DNA damage response
    Marazita, Mariela C., Ogara, M. Florencia, Sonzogni, Silvina V., Martí, Marcelo, Dusetti, Nelson J., Pignataro, Omar P., Cánepa, Eduardo T. · 2012 · PLoS ONE
  6. WD40-repeat protein WDR18 collaborates with TopBP1 to facilitate DNA damage checkpoint signaling
    Yan, Shan, Willis, Jeremy · 2013 · Biochemical and Biophysical Research Communications
  7. Biology and Therapeutic Properties of Mesenchymal Stem Cells in Leukemia
    Wu, Cheng-Hsien, Weng, Te-Fu, Li, Ju-Pi, Wu, Kang-Hsi · 2024 · International Journal of Molecular Sciences
  8. The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia
    Rimmelé, Pauline, Esposito, Michela, Delestré, Laure, Guervilly, Jean-Hugues, Ridinger-Saison, Maya, Despras, Emmanuelle, Moreau-Gachelin, Françoise, Rosselli, Filippo, Guillouf, Christel · 2017 · Oncotarget